Alzheimer’s disease seminar
DRA symposium
Alzheimer's disease is a devastating disease, which affects millions of people worldwide. But despite extensive research, numerous questions are still left unanswered. What causes the disease and which pathological hallmarks are relevant for (pharmacological) interventions?
This seminar combines national and international recognized experts from the clinic, academia, and spinout providing overview and novel insights to the disease, current treatment options, and potential future therapeutic interventions.
Sign up via ALZHEIMER’S DISEASE seminar - Danmarks Farmaceutiske Selskab (farmaceutisk-selskab.dk)
Programme
| 16:15-16:30 | Coffee & snacks |
| 16:30-16:35 |
Welcome by the Danish Pharmaceutical Society |
| 16:35-17:15 |
Alzheimer’s disease – the disease and current standard care Kristian Steen Frederiksen, Associate Professor, Senior Hospital Physician |
| 17:15-17:45 |
Brain energy accounting in Alzheimer’s disease Blanca Aldana, Associate Professor |
| 17:45-18:05 | Refreshments |
| 18:05-18:35 |
The story of Lecanemab: From bench to bedside Dag Sehlin, Associate Professor Department of Public Health and Caring Sciences, Uppsala University |
| 18:35-19:05 |
Light as novel treatment option for Alzheimer’s disease patients Jes Broeng & Marcus Carstensen, Co-founders OPTOCEUTICS |
| 19:05-19:15 |
Wrap up Mie Kristensen & Steen Ingwersen Section of Biopharmacy, Danish Pharmaceutical Society |
The symposium is organized on behalf of the graduate programme in pharmaceutical sciences, Drug Research Academy, by Associate Professor Mie Kristensen, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen in collaboration with the Section for Biopharmaceuticals, Danish Pharmaceutical Society.
The symposium is free of charge and open for attendance by all interested parties.